Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes.

Cancer biotherapy & radiopharmaceuticals - 1 May 2024

Wang Jian, Jiang Li, Shang Zhenhua, Ye Zhaohua, Yuan Dan, Cui Xin

Abstract excerpt

Background: DNA damage response (DDR) mutation-related genes and composition of immune cells are core factors affecting the effectiveness of immune checkpoint inhibitor therapy. The aim of this study is to combine DDR with immune-related genes to screen the prognostic signature for prostate cancer (PCa). Methods: Gene expression profile and somatic mutation were downloaded from The Cancer Genome Atlas (TCGA)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Damage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Nomograms

Share to Prognosis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 37610864
DOI: 10.1089/cbr.2023.0033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes.PMID 37610864Read ↗

Development of a Novel Immune-Related Prognostic Signature for Prostate CancerSemantic proximity Read ↗

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.Semantic proximity Read ↗

Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancerSemantic proximity Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate CancerSemantic proximity Read ↗

Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity Read ↗

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate CancerSemantic proximity Read ↗

A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancerSemantic proximity Read ↗

Immune-related biomarker risk score predicts prognosis in prostate cancer.Semantic proximity Read ↗

Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancerSemantic proximity Read ↗

Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancerSemantic proximity Read ↗

A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.